Video

Michelle Apperson From UC Davis: Encouraging Clinical Trials for Multiple Sclerosis Patients Helps Greater Good

Author(s):

As more treatments for multiple sclerosis are developed patients can help not only those affected by the condition now but also those in the future as well by enrolling in properly conducted clinical trials.

As more treatments for multiple sclerosis are developed patients can help not only those affected by the condition now but also those in the future as well by enrolling in properly conducted clinical trials.

Michelle Apperson, MD, PhD, Director of the Multiple Sclerosis Program and an assistant clinical professor at University of California, Davis, discussed the importance of patients engaging in these trials during the annual ACTRIMS meeting in New Orleans. Apperson noted that trials later in development are often the safest for patients and said those listed on the website clinicaltrials.gov follow a strict protocol to ensure patient health and safety through the process.

Related Videos
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Developing Risk Assessment Tools for Viruses in School
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
What Should the American Academy of Physician Associates Focus on in 2025?
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
© 2024 MJH Life Sciences

All rights reserved.